Target intelligence / Profile preview

DSTN pseudogene 1 (DSTNP1)

Target
DSTNP1
Molecular classification
Pseudogene, Processed pseudogene, Non-coding RNA
01

Overview

DSTN pseudogene 1 (DSTNP1) is a processed pseudogene related to the Destrin (DSTN) gene, which encodes an actin-binding protein involved in cytoskeletal dynamics. As a processed pseudogene, DSTNP1 does not code for a functional protein but produces RNA transcripts. Recent studies indicate that such pseudogenes can influence the expression of their parental gene through mechanisms such as competing for shared microRNAs (miRNA sponging) or through RNA modifications like N6-methyladenosine (m^6A), which can modulate RNA stability[3]. In particular, DSTNP2 (another DSTN pseudogene) was shown to regulate DSTN expression via ceRNA effects and m^6A-dependent RNA degradation, suggesting that DSTNP1 may have analogous regulatory roles, though direct experimental evidence for DSTNP1's own function is lacking[3]. Pseudogenes like DSTNP1 are generally not considered therapeutic targets but may be relevant in gene expression regulatory networks.\n\nKey points:\n- DSTNP1 is a pseudogene, not a gene coding for a functional protein.\n- It is not a therapeutic target and has no direct role as a receptor, enzyme, or druggable entity.\n- Its biological role, if any, is at the RNA level (regulatory), potentially impacting the expression of DSTN via ceRNA or RNA modification mechanisms[3].\n- No known disease roles or biomarker use are established for DSTNP1.\n- The entry appears incorrect if the intent was to identify an actionable therapeutic target, as DSTNP1 is a non-coding, non-target pseudogene.

Other names
DSTN-pseudogene 1
02

Biological functions

Competitive endogenous RNA (ceRNA) decoyRegulation of parental gene expression through miRNA sponging and possibly m^6A modificationsNon-coding regulatory role
03

Disease associations

Other (pseudogenes can impact tumor biology by regulating oncogene/tumor suppressor levels, but no direct implication for DSTNP1 found so far [2][3].)

Beyond the preview

Go deeper on DSTN pseudogene 1 (DSTNP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DSTN pseudogene 1 (DSTNP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call